top of page
Our Company
Our Team
Our Partners
Our Technology
Clinical Projects
Our Patents
Our Pipelines
Precision Medicine
Biosimilar
Cell Therapy
Media
Contact Us
More
Use tab to navigate through the menu items.
MEDIA
08/26/2021
Mabwell and FEGO Reached Cooperation Agreement on the Commercialization of a Proposed Biosimilar of Adalimumab
迈威生物与FEGO达成战略合作，推进阿达木单抗生物类似药在新加坡的商业化
Learn More
bottom of page
